Clinical trial

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00057837

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention G-CSF Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Cisplatin Normalized identity: cisplatinView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Etoposide Normalized identity: etoposideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Irinotecan Normalized identity: irinotecanView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Topotecan Normalized identity: topotecanView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-07-14

PhasePHASE2

Conditions

Extensive Stage Small Cell Lung Cancerunresolved

Interventions

G-CSFBIOLOGICAL

CisplatinDRUG · verified · RxNorm: cisplatin

EtoposideDRUG · verified · RxNorm: etoposide

IrinotecanDRUG · verified · RxNorm: irinotecan

TopotecanDRUG · verified · RxNorm: topotecan

Sponsors & collaborators

Eastern Cooperative Oncology Grouplead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

WichitaKansas, United States5 Sioux FallsSouth Dakota, United States3 KalamazooMichigan, United States3 South BendIndiana, United States3 UrbanaIllinois, United States2 PhiladelphiaPennsylvania, United States1 BaltimoreMaryland, United States1 MiamiFlorida, United States1 ClevelandOhio, United States1 JacksonvilleFlorida, United States1 The BronxNew York, United States1 New BrunswickNew Jersey, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00057837 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.